Related references
Note: Only part of the references are listed.Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
Yevgeniy Balagula et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
MOMETASONE FUROATE EFFECT ON ACUTE SKIN TOXICITY IN BREAST CANCER PATIENTS RECEIVING RADIOTHERAPY: A PHASE III DOUBLE-BLIND, RANDOMIZED TRIAL FROM THE NORTH CENTRAL CANCER TREATMENT GROUP N06C4
Robert C. Miller et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Cutaneous side effects of EGFR inhibitors - appearance and management
A. Wollenberg et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2010)
Comparative Evaluation of Antipruritic Protocols in Acute Burns. The Emerging Value of Gabapentin in the Treatment of Burns Pruritus
Ioannis Goutos et al.
JOURNAL OF BURN CARE & RESEARCH (2010)
Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer
Mario E. Lacouture et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia
T. Eames et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Side-Effects of Long-Term Administration of Erlotinib in Patients with Non-small Cell Lung Cancer
Annemarie Becker et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Isotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer
Paolo Bidoli et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Aprepitant for Erlotinib-Induced Pruritus
Bruno Vincenzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4)
Aminah Jatoi et al.
ONCOLOGIST (2010)
Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists
Jessica C. Hassel et al.
ONKOLOGIE (2010)
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group
Mario E. Lacouture et al.
SUPPORTIVE CARE IN CANCER (2010)
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study
D. Rigopoulos et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors
A. Osio et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Toxicity of Targeted Therapy in Non-Small-Cell Lung Cancer Management
Serena Ricciardi et al.
CLINICAL LUNG CANCER (2009)
Erlotinib-Induced Skin Rash in Patients with Non-Small-Cell Lung Cancer: Pathogenesis, Clinical Significance, and Management
Sotirios Tsimboukis et al.
CLINICAL LUNG CANCER (2009)
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption
Alon Scope et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Cetuximab-induced acneiform eruption and the response to isotretinoin
Pamela Vezzoli et al.
ACTA DERMATO-VENEREOLOGICA (2008)
Antimicrobial activity of sodium hypochlorite and chlorhexidine by two different tests
Luciana M. Sassone et al.
AUSTRALIAN ENDODONTIC JOURNAL (2008)
Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Metastatic or Advanced-stage Nonsmall Cell Lung Cancer A Multicenter Phase 2 Study
Chandra P. Belani et al.
CANCER (2008)
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes - Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)
Aminah Jatoi et al.
CANCER (2008)
Efficacy and skin toxicity management with cetuximab in metastatic colorectal cancer: Outcomes from an oncologic/dermatologic cooperation
Patrizia Racca et al.
CLINICAL COLORECTAL CANCER (2008)
Increased oral mucositis after IMRT versus Non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: Preliminary results of RTOG 0234
D. Khuntia et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Topical minocycline for managing symptoms of recurrent aphthous stomatitis
Meir Gorsky et al.
SPECIAL CARE IN DENTISTRY (2008)
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption
Alon Scope et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
Elise A. Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Evaluation of early and late Toxicities in chemoradiation trials
Soren M. Bentzen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism
Joseph Jackson et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women
Iltefat Hamzavi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Orofacial pain in cancer: Part II - Clinical perspectives and management
J. B. Epstein et al.
JOURNAL OF DENTAL RESEARCH (2007)
Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management
Jenny C. Hu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: Survey results
Susan L. Boone et al.
ONCOLOGY (2007)
Updated clinical practice guidelines for the prevention and treatment of mucositis
Dorothy M. Keefe et al.
CANCER (2007)
Phase II clinical trial of chemotherapy-naive patients >= 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
David M. Jackman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: A randomized clinical trial
Majid Shohrati et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2007)
Efficacy of pregabalin in the management of cetuximab-related itch
Giampiero Porzio et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: A randomized trial
Stacy R. Smith et al.
DERMATOLOGIC SURGERY (2006)
Mechanisms of cutaneous toxicities to EGFR inhibitors
Mario E. Lacouture
NATURE REVIEWS CANCER (2006)
Description and management of cutaneous side effects during cetuximab or erlotinib treatments:: A prospective study of 30 patients
Esther Roe et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: A double-blind, randomized study
Li-Ching Lin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Phase III trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck:: Results of radiation therapy oncology group trial 99-13
EA Elliott et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group study S0126
HL West et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab
KY Suh et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Cutaneous side effects of EGF-receptor inhibition and their management
R Gutzmer et al.
HAUTARZT (2006)
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
EEW Cohen et al.
CLINICAL CANCER RESEARCH (2005)
Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy
R Gutzmer et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
HER1/EGFR inhibitor-associated rash:: Future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum
R Pérez-Soler et al.
ONCOLOGIST (2005)
Practical management of patients with non-small-cell lung cancer treated with gefitinib
NT Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
S Segaert et al.
ANNALS OF ONCOLOGY (2005)
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
AW Lucky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Prophylactic effect of pentoxifylline on radiotherapy complications: A clinical study
E Aygenc et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2004)
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
R Pérez-Soler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: A multicenter phase II trial
HQ Xiong et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cetuximab - In the treatment of metastatic colorectal cancer
NA Reynolds et al.
DRUGS (2004)
Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial
AI Gunal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck
D Soulieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
EB Rubenstein et al.
CANCER (2004)
The efficacy of silver nitrate cauterization for pyogenic granuloma of the hand
HM Quitkin et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2003)
Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma
RJ Motzer et al.
INVESTIGATIONAL NEW DRUGS (2003)
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: An open, randomized double-blind and double dummy study
A Tosti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
The impact of skin washing with water and soap during breast irradiation: a randomized study
I Roy et al.
RADIOTHERAPY AND ONCOLOGY (2001)
Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid
U Wollina
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2001)
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
KJ Busam et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Share Paper
